Stockreport

Surf Therapeutics Reports Positive First-in-Human Data and Secures Additional Financing, Bringing Total Funding to $6M as Rheumatoid Arthritis Clinical Study Begins [Yahoo! Finance]

Rani Therapeutics Holdings, Inc. - Class A  (RANI) 
PDF therapies to treat immune-mediated diseases, today reported positive first-in-human study results and announced the close of an extension seed financing round, bringing [Read more]